All experiments were performed with siRNA knockdown since attempts to produce SERBP1 knockout lines using the CRISPR-Cas9 approach were not successful, suggesting that at least the GBM lines we tested are unable to survive without SERBP1 function. This evidence concerns the gene SERBP1 and glioblastoma.